Bio Other Operating Expenses from 2010 to 2024
BGT Stock | 0.04 0 2.44% |
Other Operating Expenses | First Reported 2016-09-30 | Previous Quarter 1.4 M | Current Value 1.7 M | Quarterly Volatility 750.4 K |
Check Bio Gene financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bio Gene's main balance sheet or income statement drivers, such as Depreciation And Amortization of 39.4 K, Interest Expense of 63.8 K or Selling General Administrative of 1.5 M, as well as many indicators such as . Bio financial statements analysis is a perfect complement when working with Bio Gene Valuation or Volatility modules.
Bio | Other Operating Expenses |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Bio Stock Analysis
When running Bio Gene's price analysis, check to measure Bio Gene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Gene is operating at the current time. Most of Bio Gene's value examination focuses on studying past and present price action to predict the probability of Bio Gene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Gene's price. Additionally, you may evaluate how the addition of Bio Gene to your portfolios can decrease your overall portfolio volatility.